April 29, 2026
1 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
An FDA initiative to implement real-time clinical trials could dramatically accelerate the pace at which new treatments become available to patients, according to physicians from two institutions involved in the effort’s initial phase. The approach will leverage electronic health records and an AI-powered platform to allow FDA scientists to track safety signals and efficacy endpoints while
April 29, 2026
1 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Monitoring trials in real time may help shorten the time interval between trial phases.

We are living in an exciting new era for Alzheimer’s treatment. For the first time, therapies can slow the disease for some…

HHS Secretary Robert F. Kennedy Jr. wants to speed up clinical trials in the United States.“A recent study found that China…

Doceree Launches Clinical Intent Signals, the Industry's First Real-Time Clinical Intent Layer for Omnichannel Healthcare…

“Nearly 30% of the data collected in clinical trials do not directly inform key decisions, yet patients are still asked to…

EDETEK to Support the FDA's Real-Time Clinical Trials Initiative with Its R&D Cloud and Sponsor Partnership Program